From REUTERS – by Lewis Krauskopf and Bill Berkrot
Vertex Pharmaceuticals Inc’s highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and
Image via Wikipedia
setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
